Total Funding
34
61
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
111028
Kermode Biotechnologies is a biotechnology company that focused on genetic composition and replication cycles of animal viruses.
- Thomas Malcolm: Co-Founder and COOPast Role: Excision BioTherapeutics, Founder
- Dan Chen: Chief Executive Officer
About the Company
Kermode Biotechnologies focuses on solving the challenges of animal health. The company's focus is on livestock viruses such as African Swine Fever Virus (ASFV) and Swine Flu (SIV or S-OIV).
Kermode utilizes computational approaches to define vulnerable targets in viral structure, genetic composition, and replication cycles. Once these
targets are defined, the company deploys antibody discovery platforms to isolate therapeutic candidates with the highest potential to protect livestock against viral infections. This approach will allow Kermode to identify strong antibody therapeutics and construct vaccine candidates with long-lasting in vivo responses.
